Making antimalarial agents available in Africa

New England Journal of Medicine

Volumn 353, Issue 4, 2005, Pages 333-335

  Arrow, Kenneth J ^a   Gelband, Hellen ^b   Jamison, Dean T ^c  

^a STANFORD UNIVERSITY   (United States)

^b INSTITUTE OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTEMISIN; CHLOROQUINE; ARTEMISININ DERIVATIVE;

AFRICA; DRUG COST; DRUG EFFICACY; DRUG MARKETING; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HUMAN; MALARIA; MONOTHERAPY; POVERTY; PRIORITY JOURNAL; SHORT SURVEY; ARTICLE; DRUG COMBINATION; DRUG RESISTANCE; ECONOMICS; HEALTH CARE DELIVERY; ORGANIZATION AND MANAGEMENT;

AFRICA; ANTIMALARIALS; ARTEMISININS; CHLOROQUINE; DELIVERY OF HEALTH CARE; DRUG COSTS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALARIA;

EID: 22844445926     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp058168     Document Type: Short Survey

References (2)

1. Arrow KJ, Panosian CB, Gelband H. Saving lives, buying time: economics of malaria drugs in an age of resistance. Washington, D.C.: National Academies Press, 2004.
2. UNICEF. The Africa malaria report 2003. Geneva: World Health Organization, 2003.